Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00719654 · ClinicalTrials.gov registry record
Alterations in the Plasma Proteome of Early-Onset Severe Preeclampsia
A clinical trial, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- 316
- Enrollment target
NCT00719654 is a clinical trial that has completed, run by Medical University of South Carolina. The registered enrollment target is 316 participants.
The verdict
NCT00719654 has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- 316 participants
- Enrollment target
Study Summary
The hypothesis of this study is that many plasma proteins are altered in concentration and structure in preeclampsia and the elucidation of these alterations will add to the poorly understood pathophysiology of preeclampsia. In this study we will compare the maternal plasma proteomes of early-onset severe preeclampsia versus healthy controls, compare protein expression and quantification of the maternal plasma proteome at the time of diagnosis of EOS-preeclampsia to the plasma proteome of the same affected subject at 48 hours post delivery and we will verify the placental expression of differentially expressed or post-translationally modified proteins found in the plasma of women with EOS-preeclampsia.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 316 participants |
| Start Date | 2007-08 |
| Est. Completion | 2012-04-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00719654
The ClinicalTrials.gov registry entry for NCT00719654 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 316 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00719654 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00719654 about?
NCT00719654 is a clinical study titled "Alterations in the Plasma Proteome of Early-Onset Severe Preeclampsia". The hypothesis of this study is that many plasma proteins are altered in concentration and structure in preeclampsia and the elucidation of these alterations will add to the poorly understood pathophysiology of preeclampsia. In this study we will compare the maternal plasma proteomes of early-onset ...
What is the current status of trial NCT00719654?
This trial is currently completed. The enrollment target is 316 participants. The study started on 2007-08. Estimated completion is 2012-04-09.
Who is sponsoring clinical trial NCT00719654?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.